---
title: Current research on metformin and its limitations
videoId: sFbghkE0WYo
---

From: [[⁨cleoabram⁩]] <br/> 
## Metformin: A Potential Anti-Aging Drug?

Recent discussions have highlighted the drug Metformin, previously known for its use in diabetes treatment, as potentially offering new benefits <a class="yt-timestamp" data-t="00:00:04">[00:00:04]</a>. It has been described as "the first [[metformin_as_an_antiaging_drug | anti-aging drug]]" or a "possible [[metformin_as_an_antiaging_drug | anti-aging drug]]" <a class="yt-timestamp" data-t="00:00:10">[00:00:10]</a>. This attention comes from a shift in interest from its traditional role to its potential for extending lifespan <a class="yt-timestamp" data-t="00:00:31">[00:00:31]</a>.

### What is Metformin?

Metformin is a legitimate drug that has been used effectively for decades by people with [[metformins_effects_on_diabetes | diabetes]] to control their blood sugar levels <a class="yt-timestamp" data-t="00:00:22">[00:00:22]</a>. It is also very affordable, costing only pennies per pill <a class="yt-timestamp" data-t="00:00:27">[00:00:27]</a>.

### Dispelling "Fountain of Youth" Myths

Dr. Nir Barzilai, an expert on aging, clarifies that the focus is not on finding a "fountain of youth" that can make an old person young again <a class="yt-timestamp" data-t="00:01:15">[00:01:15]</a>, <a class="yt-timestamp" data-t="00:01:24">[00:01:24]</a>. He cautions against "charlatans" in the anti-aging field <a class="yt-timestamp" data-t="00:00:53">[00:00:53]</a>. Instead, researchers aim to delay the effects of aging, particularly the increased chance of dying from common diseases that comes with age <a class="yt-timestamp" data-t="00:01:30">[00:01:30]</a>, <a class="yt-timestamp" data-t="00:01:41">[00:01:41]</a>.

Dr. Barzilai suggests that diseases like [[current_methods_for_cancer_treatment | cancer]], heart disease, and Alzheimer's increase with age because of the underlying "biology of aging" <a class="yt-timestamp" data-t="00:01:45">[00:01:45]</a>, <a class="yt-timestamp" data-t="00:01:51">[00:01:51]</a>. He hypothesizes that if the biology of aging can be stopped, these diseases could also be stopped <a class="yt-timestamp" data-t="00:01:55">[00:01:55]</a>. The idea is that bodies accumulate damage over time, leading to these diseases, and delaying this damage could delay the diseases, increasing longevity <a class="yt-timestamp" data-t="00:02:02">[00:02:02]</a>, <a class="yt-timestamp" data-t="00:02:16">[00:02:16]</a>.

### Key UK Study Findings (2014)

In 2014, Dr. Barzilai encountered a significant UK study involving approximately 180,000 people <a class="yt-timestamp" data-t="00:02:23">[00:02:23]</a>, <a class="yt-timestamp" data-t="00:02:28">[00:02:28]</a>. The study compared three groups:
*   People with [[metformins_effects_on_diabetes | diabetes]] taking metformin <a class="yt-timestamp" data-t="00:02:36">[00:02:36]</a>
*   People with [[metformins_effects_on_diabetes | diabetes]] taking other non-metformin drugs <a class="yt-timestamp" data-t="00:02:40">[00:02:40]</a>
*   People without [[metformins_effects_on_diabetes | diabetes]] who were not taking any [[metformins_effects_on_diabetes | diabetes]] drugs <a class="yt-timestamp" data-t="00:02:43">[00:02:43]</a>

The study revealed that people with [[metformins_effects_on_diabetes | diabetes]] not on metformin had double the mortality rate compared to people without [[metformins_effects_on_diabetes | diabetes]] <a class="yt-timestamp" data-t="00:02:47">[00:02:47]</a>. Intriguingly, people with [[metformins_effects_on_diabetes | diabetes]] taking metformin, who were often more obese and sicker to begin with, had *less* mortality than people *without* [[metformins_effects_on_diabetes | diabetes]] <a class="yt-timestamp" data-t="00:02:54">[00:03:01]</a>.

### Limitations of Existing Studies

Despite the compelling findings, there are significant caveats when applying this to [[metformin_as_an_antiaging_drug | anti-aging]]:
*   **Correlation vs. Causation**: The UK study was retrospective, meaning it looked back at past data and could not determine if metformin *caused* the lower mortality <a class="yt-timestamp" data-t="00:03:19">[00:03:19]</a>.
*   **Diabetic-Specific Data**: The study only included people with [[metformins_effects_on_diabetes | diabetes]] who were taking metformin, so it's not clear if the "dying less" effect applies to individuals without [[metformins_effects_on_diabetes | diabetes]] <a class="yt-timestamp" data-t="00:03:27">[00:03:27]</a>, <a class="yt-timestamp" data-t="00:03:31">[00:03:31]</a>.

### How Metformin Works: Knowns and Unknowns

For people with [[metformins_effects_on_diabetes | diabetes]], metformin helps control high blood sugar levels by affecting how the body transports sugars to cells for fuel <a class="yt-timestamp" data-t="00:03:40">[00:03:40]</a>, <a class="yt-timestamp" data-t="00:03:47">[00:03:47]</a>. Research on this mechanism dates back decades <a class="yt-timestamp" data-t="00:03:52">[00:03:52]</a>.

However, much less is known about how metformin might work for [[metformin_as_an_antiaging_drug | anti-aging]] in people without [[metformins_effects_on_diabetes | diabetes]] <a class="yt-timestamp" data-t="00:03:56">[00:03:56]</a>. A major reason for this lack of research is that metformin is now a cheap generic drug, reducing incentives for pharmaceutical companies to fund expensive new studies <a class="yt-timestamp" data-t="00:04:03">[00:04:03]</a>. While other studies suggest metformin has [[metformin_as_an_antiaging_drug | anti-aging]] effects in healthy mice and worms, human trials are needed <a class="yt-timestamp" data-t="00:04:12">[00:04:12]</a>.

### Current Research: The TAME Study

To address these limitations, Dr. Barzilai is leading a new nationwide study called TAME (Targeting Aging with Metformin) <a class="yt-timestamp" data-t="00:04:23">[00:04:23]</a>, <a class="yt-timestamp" data-t="00:04:36">[00:04:36]</a>, <a class="yt-timestamp" data-t="00:04:41">[00:04:41]</a>. This will be a randomized trial where half the participants receive metformin and the other half a placebo <a class="yt-timestamp" data-t="00:04:29">[00:04:29]</a>. The goal is to conduct a study for the FDA to potentially repurpose metformin as a drug that targets aging <a class="yt-timestamp" data-t="00:04:48">[00:04:48]</a>.

If this research proves successful, it would be revolutionary, suggesting that aging could be treatable, potentially delaying the accumulation of damage and the onset of diseases that cause the most deaths <a class="yt-timestamp" data-t="00:05:01">[00:05:01]</a>.

### Personal Considerations for Metformin Use

For individuals considering taking metformin for [[metformin_as_an_antiaging_drug | anti-aging]] outside of a [[metformins_effects_on_diabetes | diabetes]] diagnosis, the decision hinges on three factors:
1.  **Assessment of Existing Studies**: How compelling do you find the current, non-TAME trial data? <a class="yt-timestamp" data-t="00:05:52">[00:05:52]</a>
2.  **Urgency of Aging**: How urgently do you perceive the process of aging for yourself? This is a personal choice <a class="yt-timestamp" data-t="00:05:57">[00:05:57]</a>.
3.  **Weighing Benefits Against [[potential_side_effects_and_considerations_of_metformin_use | Side Effects]]**: How do the potential benefits compare to the known [[potential_side_effects_and_considerations_of_metformin_use | side effects]]? <a class="yt-timestamp" data-t="00:06:03">[00:06:03]</a>

### [[potential_side_effects_and_considerations_of_metformin_use | Potential Side Effects and Considerations]]

Metformin has common [[potential_side_effects_and_considerations_of_metformin_use | side effects]], particularly in the first week of use. These include:
*   Early satiety (feeling full quickly) <a class="yt-timestamp" data-t="00:06:07">[00:06:07]</a>
*   Upset stomach <a class="yt-timestamp" data-t="00:06:15">[00:06:15]</a>
*   Diarrhea <a class="yt-timestamp" data-t="00:06:18">[00:06:18]</a>

It also affects how the body responds to exercise. While exercise still increases muscle capacity, the muscle itself may not become as large <a class="yt-timestamp" data-t="00:06:20">[00:06:20]</a>, <a class="yt-timestamp" data-t="00:06:23">[00:06:23]</a>, <a class="yt-timestamp" data-t="00:06:30">[00:06:30]</a>.

Journalists working on this topic emphasize the importance of presenting valuable information while cautioning against self-medication based solely on a video <a class="yt-timestamp" data-t="00:07:10">[00:07:10]</a>, <a class="yt-timestamp" data-t="00:07:17">[00:07:17]</a>. The personal decision often involves waiting for more definitive studies, such as the TAME trial <a class="yt-timestamp" data-t="00:07:22">[00:07:22]</a>.

### The Broader Hope for Aging Research

The potential to meaningfully delay the effects of aging is immense <a class="yt-timestamp" data-t="00:07:34">[00:07:34]</a>. Globally, 18 million people die from heart disease each year, 10 million from [[current_methods_for_cancer_treatment | cancer]], and 55 million live with Alzheimer's or other dementias <a class="yt-timestamp" data-t="00:07:44">[00:07:44]</a>. Finding a way to extend healthy lifespan would mean more time with loved ones for millions <a class="yt-timestamp" data-t="00:08:04">[00:08:04]</a>.